SCHEMBL26415

SCHEMBL26415

Cc1oc(=O)oc1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3956919 0.89 FOLH1 (0.32)
SCHEMBL10914516 0.83 KDM4E (0.32)
SCHEMBL18087888 0.82
SCHEMBL102100 0.79
SCHEMBL950801 0.79
SCHEMBL14533353 0.78 FOLH1 (0.34)
SCHEMBL5670054 0.77
SCHEMBL3697627 0.77
SCHEMBL22324600 0.77 KDM4E (0.30)
SCHEMBL17517907 0.77 FOLH1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 897 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117126150-B Preparation method of azilsartan medoxomil potassium salt impurity a 仁合益康集团有限公司 2026-05-15 CN claimed
US-12365662-B2 Process for 4-(hydroxymethyl)-5-methyl-1,3-dioxol-2-one PIRAMAL PHARMA LIMITED (IN) 2025-07-22 US claimed
CN-118239936-A Preparation method of azilsartan medoxomil amide derivative 珠海润都制药股份有限公司 2024-06-25 CN claimed
CN-117126150-A Preparation method of azilsartan medoxomil potassium salt impurity a 仁合益康集团有限公司 2023-11-28 CN claimed
EP-3856747-B1 SUBSTITUTED PYRIDOINDOLES FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION HOFFMANN LA ROCHE (CH) 2023-07-19 EP claimed
CN-113912580-B Method for purifying 4- (hydroxymethyl) -5-methyl- [1,3] dioxol-2-one 瑞孚信江苏药业股份有限公司 2023-06-02 CN claimed
CN-115894472-A Preparation method of high-purity azilsartan medoxomil potassium salt 仁合益康集团有限公司 2023-04-04 CN claimed
US-20220372011-A1 AN IMPROVED PROCESS FOR 4-(HYDROXYMETHYL)-5-METHYL-1,3-DIOXOL-2-ONE PIRAMAL PHARMA LIMITED (IN) 2022-11-24 US claimed
CN-111646971-B Method for synthesizing 4- (hydroxymethyl) -5-methyl- [1,3] dioxol-2-one 河南省三生药业有限公司 2022-05-31 CN claimed
CN-113912580-A Method for purifying 4- (hydroxymethyl) -5-methyl- [1,3] dioxol-2-one 瑞孚信江苏药业股份有限公司 2022-01-11 CN claimed
EP-0691959-B1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LTD (GB) 1998-07-22 EP claimed
WO-1998026768-A2 USE OF 7-(1-AMINOMETHYL-2-OXA-7-AZA-BICYCLO[3.3.0]OCT-7-YL)-QUINOLONE CARBOXYLIC ACID AND NAPHTHYRIDONE CARBOXYLIC ACID DERIVATIVES FOR TREATING HELICOBACTER PYLORI INFECTIONS AND THE GASTRODUODENAL DISEASES ASSOCIATED THEREWITH BAYER AKTIENGESELLSCHAFT (DE) 1998-06-25 WO claimed
EP-0721948-B1 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents BAYER AG (DE) 1997-12-03 EP claimed
US-5679689-A BACTERICIDES BAYER AKTIENGESELLSCHAFT (DE) 1997-10-21 US claimed
EP-0721948-A1 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents BAYER AG (DE) 1996-07-17 EP claimed
EP-0705828-A1 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents BAYER AG (DE) 1996-04-10 EP claimed
EP-0691959-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-17 EP claimed
WO-1994022834-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO claimed
EP-0267378-B1 TROPOLONE DERIVATIVES AS AN ANTI-MYCOPLASMA AGENT SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI &amp; CO. LTD. (JP) 1992-11-04 EP claimed
EP-0267378-A2 Tropolone derivatives as an anti-mycoplasma agent SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI &amp; CO. LTD. (JP) 1988-05-18 EP claimed